Immunosenescence: molecular mechanisms and diseases.

Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, Cheng Q, Luo P, Zhang Y, Han X. · 2023

Read Immunosenescence: molecular mechanisms and diseases. by Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, Cheng Q, Luo P, Zhang Y, Han X. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10182360.txt.

Introduction

Liu and a large team review immunosenescence, the aging of the immune system, in a 2023 paper. As people grow old, their immune defenses weaken in known ways. Infections hit harder, vaccines work less well, and the risk of cancer and chronic disease climbs, while a low level of inflammation runs in the background.

The review explains the molecular changes behind this decline, in both the fast innate defenses and the slower learned ones. It links those changes to the diseases of old age. It also surveys treatments that aim to restore youthful immune function.

Catalog record

CREATORLiu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, Cheng Q, Luo P, Zhang Y, Han X.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE99 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10182360

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Immunosenescence: molecular mechanisms and diseases By Zaoqu Liu, Qimeng Liang, Yuqing Ren, Chunguang Guo, Xiaoyong Ge, Libo Wang, Quan Cheng, Peng Luo, Yi Zhang, Xinwei Han Published in: Signal Transduction and Targeted Therapy DOI: 10.1038/s41392-023-01451-2 ABSTRACT Infection susceptibility, poor vaccination efficacy, age-related disease onset, and neoplasms are linked to innate and adaptive immune dysfunction that accompanies aging (known as immunosenescence). During aging, organisms tend to develop a characteristic inflammatory state that expresses high levels of pro-inflammatory markers, termed inflammaging. This chronic inflammation is a typical phenomenon linked to immunosenescence and it is considered the major risk factor for age-related diseases. Thymic involution, naïve/memory cell ratio imbalance, dysregulated metabolism, and epigenetic alterations are striking features of immunosenescence. Disturbed T-cell pools and chronic antigen stimulation mediate premature senescence of immune cells, and senescent immune cells develop a proinflammatory senescence-associated secretory phenotype that exacerbates inflammaging. Although the underlying molecular mechanisms remain to be addressed, it is well documented that senescent T cells and inflammaging might be major driving forces in immunosenescence. Potential counteractive measures will be discussed, including intervention of cellular senescence and metabolic-epigenetic axes to mitigate immunosenescence. In recent years, immunosenescence has attracted increasing attention for its role in tumor development. As a result of the limited participation of elderly patients, the impact of immunosenescence on cancer immunotherapy is unclear. Despite some surprising results from clinical trials and drugs, it is necessary to investigate the role of immunosenescence in cancer and other age-related diseases. INTRODUCTION The increase in human life expectancy has led to a concomitant aging of the population, who are not only at higher risk for age-related diseases, including tumors, but also for a higher failure rate of immunotherapy and an increase in the recurrence rate after treatment.1,2 This phenomenon is known as immunosenescence and was first described by Roy Walford.3–7 Immunosenescence has defined the destruction and remodeling of immune organ structure as well as innate and adaptive immune dysfunction with aging, causing poor vaccination outcomes, and increased susceptibility to infection, age-related disease, and malignancies.8–11 Since the 1980s, scientists have begun to delve deeper into the mechanisms and effects of immunosenescence, and have found some important research results. Age-related declines in coping capacity and concomitant increases in proinflammatory status are the hallmarks of immunosenescence. This phenomenon, known as “inflammaging”, first proposed by Claudio Franceschi in 2000,12 is caused by constant antigen load and stress.12 In addition, thymic involution has been one of the most dramatic and ubiquitous changes.13 Immunosenescence affects both the innate and adaptive immune systems and certain immune cell types are more affected.14 In both mouse and human models, the hematopoietic stem cell (HSC) population of aged individuals had an increased frequency of immunophenotypes, was less quiescent, and showed myeloid-biased potentials, with transcriptional upregulation of genes related to cell cycle, myeloid-biased differentiation and myeloid malignancies.15 Attenuated acquired immunity is mainly associated with dwindling T-cell output, a remarkable characteristic of immunosenescence.16 The paradoxical coexistence of a massive influx of hyporesponsive tumor-infiltrating lymphocytes (TILs) in the tumor microenvironment (TME) and continued tumor aggressiveness also implies that dysfunctional T cells may hinder a successful antitumor response and immunotherapy.17–19 During immune system aging, three dysfunctional T-cell types can be observed: exhausted, senescent, and aged T cells.20,21 Among them, senescent T cells are the most studied. Senescence was originally described as a phenomenon in aged human fibroblasts both in culture and in vivo22; however, few markers were found in common between normal aging and senescence. Cellular senescence is associated with numerous cellular processes of aging, and the accumulation of senescent cells is one of the key pathological features associated with aging. Senescent cells are characterized by permanent cell cycle arrest accompanied by morphological abnormalities, loss of proliferative ability, and resistance to apoptosis.23,24 As a physiological response, it prevents genomic instability induced by persistent antigens and therefore the accumulation of DNA damage.25 However, excessive senescence, particularly of T cells, may ultimately lead to catastrophic immune decline and an increased risk of age-related diseases.26,27 Cellular senescence can be divided into premature senescence and telomere-dependent senescence (age-dependent replicative senescence).23,24,28–30 The senescence discussed in this review primarily refers to premature senescence triggered by damage signals such as oxidative stress, mitochondrial dysfunction, epigenetic changes, cytokines, perturbed proteostasis, persistent DNA damage, and mitogenic oncogenes. We summarize the significant findings in the research history of immunosenescence and illustrate the Fig. 1.Fig. 1A timeline of events in the research history of immunosenescence. In this figure, we summarize the concept regarding immunosenescence, the breakthrough discovery of molecular mechanisms and biomarkers, and draw a timeline of research history Given the dilemma of rising health care costs resulting from aging populations across the globe, gaining a comprehensive understanding of the intricate mechanisms underlying immunosenescence and senescent T cells could lead to the exploration of more effective therapeutic strategies. In this article, we focus on outlining the features of immunosenescence, its specific molecular mechanisms, and associated diseases, with particular attention to senescent T cells. We delve into the extensive metabolic and epigenetic pathways that determine T-cell fate and senescence. Additionally, we compared exhausted, senescent, and aged T cells as well as several clinical trials that have involved senescent immune cells. Based on these results, we propose possible interventional strategies targeting the metabolic-epigenetic axis of immunosenescence and senescent T cells to enhance current immunotherapy and extend life expectancy. CONCEPT AND HALLMARKS OF IMMUNOSENESCENCE Immunosenescence is a complex process that involves organ reorganization and numerous regulatory processes at the cellular level.31 As a result, immune system function decreases, leading to an inadequate response to infections or vaccines in elderly individuals. Although the full extent of the biological changes is unknown, several characteristic changes are typically observed such as thymic involution, HSC dysfunctions, disrupted naïve/memory ratio in T and B cells, inflammaging, accumulation of senescent cells, impaired new antigen response, mitochondrial dysfunction, genomic instability, and stress responses32–35 (Fig. 2). Identifying hallmarks and characteristics associated with immunosenescence is crucial for exploring its impact and significance, particularly in age-related diseases.Fig. 2Hallmarks of immunosenescence and related diseases. Various immune cell subsets changed during immunosenescence. There were significant changes in T-cell subpopulations, including a decline in T-cell production associated with age due to thymic degeneration, abnormal T-cell metabolism, changes in the proportion of T subpopulations, and an SASP-mediated chronic low-grade inflammatory environment. IFN-γ interferon-γ, IL-6 interleukin-6, IL-8 interleukin-8, IL-18 interleukin-18, IL-29 interleukin-29, MDSC myeloid-derived suppressor cells, NK cells natural killer cells, ROS reactive oxygen species, SASP senescence-associated secretory phenotype, TCR T-cell receptor, TNF tumor necrosis factor Thymic involution plays a vital role in the imbalance of immune cell proportions, particularly for T cells.36–38 Thymic tissue can be divided into epithelial tissue and nonepithelial perivascular space without thymopoiesis. As the thymus atrophies, the epithelial spaces gradually disappear, and the perivascular space gradually fills the elderly thymus, leading to a decrease in naïve T cells, an increase in peripheral late-differentiated memory T cells, and diminished migration of naïve T cells to the periphery.39–41 Recent research has found that young adults who underwent thymectomy in early childhood for congenital heart disease displayed premature immunosenescence compared with age-matched adults, with altered T-cell profiles commonly seen in elderly individuals. This provides much-needed evidence for the role of thymic involution in human immune system aging.42 According to the

Read the complete text